Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro

Norman Simpson1, Antonella Maffei, Matthew Freeby

  • 1Division of Endocrinology, Department of Medicine, Columbia University Medical College, 650 West 168th Street, BB 2006, New York, New York 10032, USA.

Insights

Dopamine (DA) released from human islet cells during glucose stimulation acts as a brake on insulin secretion. Blocking this dopamine signaling pathway enhances insulin release, potentially explaining side effects of certain medications.

Area of Science:

  • Endocrinology
  • Neuroscience
  • Cell Biology

Background:

  • Glucose-stimulated insulin secretion (GSIS) is crucial for maintaining glucose homeostasis.
  • Autocrine regulatory mechanisms within pancreatic beta cells fine-tune insulin release.
  • The role of neurotransmitters like dopamine in islet function is not fully elucidated.

Purpose of the Study:

  • To investigate the role of dopamine in regulating glucose-stimulated insulin secretion in human islets.
  • To identify the specific molecular players involved in dopamine signaling within beta cells.
  • To explore the potential link between islet dopamine signaling and metabolic side effects of medications.

Main Methods:

  • Purified human islets were used for in vitro experiments.
  • Chronoamperometry was employed to measure dopamine release.
  • In vitro glucose-stimulated insulin secretion assays were performed.
  • Pharmacological antagonism of dopamine receptors (D2R) was utilized.

Main Results:

  • Dopamine (DA) is released from human beta cells upon glucose stimulation.
  • DA is stored in secretory granules via vesicular monoamine transporter type 2 (VMAT2).
  • DA acts as a negative autocrine regulator of insulin secretion by binding to D2 receptors on beta cells.
  • Antagonism of D2 receptors significantly increased glucose-stimulated insulin secretion.

Conclusions:

  • A novel negative feedback loop involving dopamine in human islet autocrine regulation of insulin secretion has been identified.
  • This dopamine-D2 receptor pathway provides a brake on insulin release, modulated by glucose levels.
  • These findings offer insights into the metabolic consequences, such as increased adiposity, associated with atypical antipsychotic use, which can affect dopamine signaling.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral stimuli,...
Feedback Loops01:01

Feedback Loops

In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.